Chlormadinone
| Clinical data | |
|---|---|
| Other names | Chlordione; 17α-Hydroxy-6-chloro-6-dehydroprogesterone; 17α-Hydroxy-6-chloropregna-4,6-diene-3,20-dione; 6-Chloro-17α-hydroxypregna-4,6-diene-3,20-dione | 
| ATC code | |
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.016.185 | 
| Chemical and physical data | |
| Formula | C21H27ClO3 | 
| Molar mass | 362.89 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Chlormadinone is a progestin which was never marketed. An acylated derivative, chlormadinone acetate, is used clinically as a pharmaceutical drug.
It was patented in 1958 and approved for medical use in 1963. While chlormadinone is sometimes used as a synonym for chlormadinone acetate, what is almost always being referred to is chlormadinone acetate and not chlormadinone.